# Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations

> **NCT01859377** · PHASE1 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 26 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** V0498 - A mg
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT01859377
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2013-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01859377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01859377, "Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01859377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*